COHA is the trusted cancer treatment center that has been providing comprehensive hematology-oncology services throughout the community of Columbia, Stevensville, Glen Burnie, and Annapolis, Maryland, for more than 25 years.
Eastern Cooperative Oncology Group performance status eCRF: electronic case report form EFS: event-free survival EMA: European Medicines Agency FAB: French-American-British FDA: Food and Drug Administration Hb: haemoglobin HD: high-dose HI: haematological improvement HU: hydroxyurea IC:...
In summary, AI has the ability to fundamentally alter cancer treatment and move it closer to the promise of precision oncology. In an era where genomics is being incorporated into health delivery and health data are being more digitized, it is anticipated that AI would be used in the construct...
The authors would like to thank Dr. Jun Chen at the Zhongshan School of Medicine, Sun Yat-Sen University, China, and Dr. Peter Y.Z. Jiang from the Department of Hematology and Oncology at The Everett Clinic and Providence Regional Cancer Partnership, USA, for critical review and suggestions...
Multiple myeloma (MM) is the second most common hematologic malignancy and remains incurable despite the advent of numerous new drugs such as proteasome inhibitors (PIs), immunomodulatory agents (IMiDs), and monoclonal antibodies. There is an unmet need
Vida Oncology is a medical practice located in Shelbyville, IN that specializes in Medical Oncology with Dr. Jaime Ayon as the Medical Director. Outpatient cancer care and blood disorders is our focus. Hematology Oncology Doctors near me.
Acute myeloid leukemia (AML) is a genetically heterogeneous clonal malignancy characterized by recurrent gene mutations. Genomic heterogeneity, patients’ individual variability, and recurrent gene mutations are the major obstacles among many factors tha
Prostate cancer (PC) is one of the most common cancers in males and the fifth leading reason of death. Age, ethnicity, family history, and genetic defects are major factors that determine the aggressiveness and lethality of PC. The African population is
The landscape of multiple myeloma (MM) has changed considerably in the past two decades regarding new treatments, insight into disease biology and innovation in the techniques available to assess measurable residual disease (MRD) as the most accurate met
Funding Dr. Hongtao Liu was supported by UCCCC pilot grant, and University of Chicago Cancer Center Support Grant (CA014599). Author information Authors and Affiliations Section of Hematology/Oncology, Department of Medicine, The University of Chicago Medical Center, 5841 S. Maryland Ave, MC 2115...